ISTANBUL MEDICAL JOURNAL, vol.23, no.4, pp.241-246, 2022 (ESCI)
Article / Article
ISTANBUL MEDICAL JOURNAL
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Intratumoral budding, neoadjuvant chemotherapy, treatment response, breast cancer, core biopsy, CHEMOTHERAPY, KI-67, PROGNOSIS, SURVIVAL
Recep Tayyip Erdoğan University Affiliated:
Introduction: Neoadjuvant chemotherapy (NAC) is used with increasing frequency in breast cancers. Various clinicopathological parameters predict treatment response (TR). Tumor budding (TB), which is a prognostic parameter in many cancers, can be considered the first stage of the metastatic process. In our study, the relationship between TR and clinicopathological parameters and TB in core biopsy samples of patients before NAC was investigated.